EnviroTech :: R&D
Jubilant, Amgen Enter Drug Discovery Deal
12:15 PM MDT | July 21, 2008 | Deepti Ramesh
Jubilant Biosys Ltd. (Bangalore, India), a subsidiary of Jubilant Organosys (Noida), says it has entered into a drug discovery partnership with biotechnology firm Amgen (Thousand Oaks, CA). The companies will collaborate to develop a novel drug portfolio across multiple therapeutic areas, Jubilant says. The agreement calls for Jubilant to develop early preclinical candidates from Amgen’s early discovery efforts, for an initial term of three years. Amgen will have responsibility for subsequent preclinical and clinical development and commercialization and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee